Schubert & Co’s QuidelOrtho QDEL Stock Holding History

Schubert & Co’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18	Closed	-$1.6K	–	1162
2023 Q1	$1.6K	Hold	18	–	–	﹤0.01%	1006
2022 Q4	$1.54K	Sell	18 -1	-5%	-$85	﹤0.01%	1000
2022 Q3	$1K	Buy	19 +6	+46%	+$537	﹤0.01%	1220
2022 Q2	$1K	Buy	13 +3	+30%	+$306	﹤0.01%	1257
2022 Q1	$1K	Buy	10 +1	+11%	+$107	﹤0.01%	872
2021 Q4	$1K	Buy	+9	New	+$1.25K	﹤0.01%	816

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Schubert & Co's QDEL Position: Q2 2023 in Review

Schubert & Co sold out of QuidelOrtho (QDEL) in Q2 2023, closing a stake of 18 shares — an estimated $1.6K sold.

Schubert & Co first reported a position in QDEL in Q4 2021 and held it in 6 quarters. The position peaked at $1.6K in Q1 2023. 313 funds tracked by Wall St. Rank hold QDEL as of Q2 2023.

Schubert & Co reported no remaining QuidelOrtho position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 18 QuidelOrtho shares in Q2 2023, an estimated $1.6K.
Schubert & Co first reported a position in QuidelOrtho in Q4 2021 and held it in 6 quarters.
Schubert & Co's QuidelOrtho position peaked at $1.6K in Q1 2023.
313 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.